sorry not your post but the answer from LC regarding cf17
As we have an FDA IND (Investigational New Drug) with CF33 and this is patient trials, any pre-clinical or clinical work has to be reported to the FDA reported under this IND so Prof. Fong wanted to use CF17 in lieu of CF33 to conduct further experiments as CF17 behaves like CF33.As expected, he got great results with CF17 and has published. IMU has the first rights to this, if we wanted to further develop CF17 as a drug however, CF33 is so much more advanced in the clinic and we believe more potent than CF17 and we would rather spend the funds on development of CF33
sorry not your post but the answer from LC regarding cf17 As we...
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.003(5.36%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 6.1¢ | 5.6¢ | $1.239M | 21.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1459482 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 633310 | 6 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |